Table3_Double-Coated Poly(butyl Cyanoacrylate) Nanoparticles as a Potential Carrier for Overcoming P-Gp- and BCRP-Mediated Multidrug Resistance in Cancer Cells.XLSX
The present study evaluates poly (butyl cyanoacrylate) nanoparticles (PBCA-NPs), double-coated with Tween 80 and polyethylene glycol (PEG) 20,000 as a potential carrier system for overcoming P-glycoprotein (P-gp) and breast cancer resistant protein (BCRP)-mediated multidrug resistance (MDR) in cancer cell lines. Doxorubicin-loaded PBCA-NPs were prepared by the anionic polymerization method and were successively double-coated with Tween 80 and PEG 20000 at varied concentrations. MDR reversing potential was investigated by cellular uptake in P-gp overexpressing cell line. And, the outcomes were verified by modified MTT assay in P-gp or BCRP overexpressing cell lines. The findings from the cell uptake study indicate that double-coated PBCA-NPs significantly enhanced doxorubicin accumulation within the cells. MTT assays revealed that double-coated PBCA-NPs significantly potentiated the sensitivity of doxorubicin in P-gp overexpressing cells, in comparison to free doxorubicin, single-, and un-coated PBCA-NPs, respectively. Moreover, further increase in concentration with Tween 80, double-coated PBCA-NPs significantly enhanced the sensitivity of doxorubicin in BCRP overexpressing cell line, in comparison to single- and double-coated formulations (with lower concentration of Tween 80). Hence, it could be concluded that double-coated PBCA-NPs can be used as a potential carrier for enhancing doxorubicin accumulation in MDR cancer cells.
History
References
- https://doi.org//10.1016/S0021-9797(03)00591-5
- https://doi.org//10.1007/978-1-60761-416-6_18
- https://doi.org//10.3390/pharmaceutics10020057
- https://doi.org//10.1002/jps.20357
- https://doi.org//10.1016/j.ijpharm.2012.01.020
- https://doi.org//10.3390/molecules23020465
- https://doi.org//10.1016/j.ctrv.2011.06.005
- https://doi.org//10.1038/nrc706
- https://doi.org//10.1016/s0927-7765(99)00156-3
- https://doi.org//10.1023/A%3A1018983904537
- https://doi.org//10.1158/0008-5472.can-03-3344
- https://doi.org//10.1002/ijc.21827
- https://doi.org//10.1002/ar.22641
- https://doi.org//10.3390/molecules24234383
- https://doi.org//10.2174/092986712800167392
- https://doi.org//10.1016/j.jconrel.2009.05.013
- https://doi.org//10.1021/la063249o
- https://doi.org//10.2147/IJN.S74378
- https://doi.org//10.1016/j.addr.2015.09.012
- https://doi.org//10.1345/aph.1E068
- https://doi.org//10.1002/1520-6017(200007)89%3A7<946%3AAID-JPS12>3.0.CO;2-2
- https://doi.org//10.1023/A%3A1016366022712
- https://doi.org//10.20517/cdr.2019.10
- https://doi.org//10.1007/BF02976689
- https://doi.org//10.1038/srep25694
- https://doi.org//10.18632/oncotarget.4493
CC BY 4.0